Role of iron chelation in improving survival: An integral part of current therapy for myelodysplastic syndromes

Role of iron chelation in improving survival: An integral part of current therapy for myelodysplastic syndromes

This review article highlights the current role of iron chelation in MDS to optimize survival and quality of life. Its role in specific subtypes of MDS is also discussed.

Bibliographic Details
Main Authors:	Sachi Jain Taran, Rakesh Taran
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2015-01-01
Series:	South Asian Journal of Cancer
Subjects:	Myelodysplastic syndromes overload quality of life survival
Online Access:	http://journal.sajc.org/article.asp?issn=2278-330X;year=2015;volume=4;issue=4;spage=186;epage=188;aulast=Taran

Similar Items

MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
by: Emanuele Angelucci, et al.
Published: (2017-03-01)

The role of magnetic resonance imaging in the evaluation of transfusional iron overload in myelodysplastic syndromes
by: Emmanouil Petrou, et al.
Published: (2015-08-01)

Clinical Efficacy of Chelation Therapy in Patients with Low-Risk Myelodysplastic Syndrome
by: SV Gritsaev, et al.
Published: (2019-03-01)

Myelodysplastic syndromes (MDS): prognostic factors and scoring systems
by: Elizabeth Xisto Souto, et al.

Emerging Therapies for the Myelodysplastic Syndromes
by: Jonathan Canaani
Published: (2019-12-01)

The Clinical Significance of Iron Overload and Iron Metabolism in Myelodysplastic Syndrome and Acute Myeloid Leukemia
by: Sarah Weber, et al.
Published: (2021-02-01)

NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
by: Francesco D'Alò, et al.
Published: (2010-08-01)

NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
by: Mariangela Greco, et al.
Published: (2010-05-01)

The myelodysplastic syndromes: diagnosis, prognosis and therapy
by: Cristina Clissa, et al.
Published: (2013-03-01)

IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
by: Rosangela Invernizzi, et al.
Published: (2015-04-01)

The Differencies in Adult and Pediatric Myelodysplastic Syndrome: A Review
by: Vasekova P, et al.
Published: (2016-08-01)

Genetics and epigenetics of myelodysplastic syndromes and response to drug therapy: new insights
by: Saeid Shahrabi, et al.
Published: (2016-12-01)

INFECTIONS IN MYELODYSPLASTIC SYNDROME IN RELATION TO STAGE AND THERAPY
by: Giuseppe Leone, et al.
Published: (2018-07-01)

ROLE AND TIMING OF HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME
by: Teresa L Field, et al.
Published: (2010-07-01)

Myelodysplastic syndromes: histopathology as prognostic factor
by: Romeo Maura, et al.
Published: (2001-01-01)

The effects of secondary iron overload and iron chelation on a radiation-induced acute myeloid leukemia mouse model
by: Lap Shu Alan Chan, et al.
Published: (2021-05-01)

Study of myelodysplastic features in patients with myelodysplastic syndromes by multicolor flow cytometry
by: O. Yu. Davydova, et al.
Published: (2019-01-01)

Immune dysregulation in myelodysplastic syndrome
by: Chiharu Sugimori, et al.
Published: (2010-01-01)

Localized lymphadenopathy with myelodysplastic syndrome associated with tuberculosis
by: Aya Nakaya, et al.
Published: (2019-11-01)

Autophagy Gene Panel-Based Prognostic Model in Myelodysplastic Syndrome
by: Ming-Jing Wang, et al.
Published: (2021-02-01)

Asian Population Is More Prone to Develop High-Risk Myelodysplastic Syndrome, Concordantly with Their Propensity to Exhibit High-Risk Cytogenetic Aberrations
by: Yan Jiang, et al.
Published: (2021-01-01)

Screening and identification of key candidate genes and pathways in myelodysplastic syndrome by bioinformatic analysis
by: Ying Le
Published: (2019-11-01)

Myelodysplastic syndrome: classification and prognostic systems
by: Rosangela Invernizzi, et al.
Published: (2011-12-01)

Treatment of High-risk Myelodysplastic Syndrome
by: LI Shijun, et al.
Published: (2020-12-01)

RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
by: Julie Schanz, et al.
Published: (2015-04-01)

Protein Carbonylation in Patients with Myelodysplastic Syndrome: An Opportunity for Deferasirox Therapy
by: Alba Rodríguez-García, et al.
Published: (2019-10-01)

Prognostic markers of efficiency of immunosupressive therapy in patients with myelodysplastic syndrome
by: Ольга Ігорівна Бойко, et al.
Published: (2015-09-01)

THROMBOCYTOPENIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - STILL AN UNSOLVED PROBLEM
by: May Basood, et al.
Published: (2018-07-01)

Abnormal Ferroptosis in Myelodysplastic Syndrome
by: Qi Lv, et al.
Published: (2020-09-01)

Genetics of Myelodysplastic Syndromes
by: Caner Saygin, et al.
Published: (2021-07-01)

Myelodysplastic syndromes: Classification
by: Hans Peter Horny
Published: (2014-01-01)

Clinical complications in outpatient myelodysplastic syndromes
by: andrea tendas, et al.
Published: (2014-08-01)

Myelodysplastic syndromes: Where do we stand?
by: Nitin Sood, et al.
Published: (2016-01-01)

Thalamic Infarction in Myelodysplastic Syndrome (Case Report)
by: Figen Güney, et al.
Published: (2008-02-01)

Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted Therapy
by: Harinder Gill, et al.
Published: (2016-03-01)

Management of Adult Patients with Myelodysplastic Syndromes
by: Nicolas Bonadies
Published: (2017-08-01)

An analysis of 30 cases of myelodysplastic syndrome
by: Shah Nilam, et al.
Published: (2009-04-01)

Summary of animal models of myelodysplastic syndrome
by: Weisha Li, et al.
Published: (2021-03-01)

Brevundimonas diminuta bacteremia in a man with myelodysplastic syndromes
by: Huiling Cao, et al.
Published: (2015-01-01)

Efficiency of cyclosporin A therapy in patients with myelodysplastic syndrome
by: A V Kokhno, et al.
Published: (2010-08-01)

Cannot write session to /tmp/vufind_sessions/sess_geenhk5l0j91qgf2igma03q77h